Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
mRNA-1273 Emergency use authorization Experimental Vaccine Dec/03/2020 4 0
Narlaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/08/2020 2 0
Telaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/08/2020 4 0
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/08/2020 7 0
Abemaciclib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/21/2020 3 0
Simvastatin Potential treatment - clinical evidence Used to treat other disease Antiviral Aug/04/2020 2 0
Atorvastatin Potential treatment - clinical evidence Used to treat other disease Antiviral Aug/04/2020 2 0
VSV-eGFP-SARS-CoV-2 Potential treatment - pre-clinical evidence Experimental Vaccine Jul/30/2020 1 0
Fluvastatin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/14/2020 1 0
PT150 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/13/2020 1 0